FI110752B - Förfarande för behandling av råmjölk - Google Patents
Förfarande för behandling av råmjölk Download PDFInfo
- Publication number
- FI110752B FI110752B FI991186A FI991186A FI110752B FI 110752 B FI110752 B FI 110752B FI 991186 A FI991186 A FI 991186A FI 991186 A FI991186 A FI 991186A FI 110752 B FI110752 B FI 110752B
- Authority
- FI
- Finland
- Prior art keywords
- milk
- colostrum
- cfmf
- cow
- filter
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 58
- 210000003022 colostrum Anatomy 0.000 title abstract description 77
- 235000021277 colostrum Nutrition 0.000 title abstract description 77
- 238000011968 cross flow microfiltration Methods 0.000 claims abstract description 28
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 235000013376 functional food Nutrition 0.000 claims abstract description 4
- 230000008569 process Effects 0.000 claims description 26
- 239000012528 membrane Substances 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 22
- 210000004080 milk Anatomy 0.000 claims description 20
- 235000013336 milk Nutrition 0.000 claims description 19
- 239000008267 milk Substances 0.000 claims description 19
- 239000011148 porous material Substances 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000009295 crossflow filtration Methods 0.000 claims description 7
- 239000002033 PVDF binder Substances 0.000 claims description 5
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 5
- 238000011146 sterile filtration Methods 0.000 claims description 5
- 241000124008 Mammalia Species 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 4
- 235000013373 food additive Nutrition 0.000 claims description 2
- 239000002778 food additive Substances 0.000 claims description 2
- 235000020247 cow milk Nutrition 0.000 claims 7
- 108060003951 Immunoglobulin Proteins 0.000 abstract description 7
- 102000018358 immunoglobulin Human genes 0.000 abstract description 7
- 235000015872 dietary supplement Nutrition 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000050 nutritive effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 21
- 210000004379 membrane Anatomy 0.000 description 20
- 239000005862 Whey Substances 0.000 description 18
- 102000007544 Whey Proteins Human genes 0.000 description 18
- 108010046377 Whey Proteins Proteins 0.000 description 18
- 238000001471 micro-filtration Methods 0.000 description 13
- 235000013351 cheese Nutrition 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- 235000020183 skimmed milk Nutrition 0.000 description 12
- 239000005018 casein Substances 0.000 description 11
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 11
- 235000021240 caseins Nutrition 0.000 description 11
- 235000013305 food Nutrition 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 108010059881 Lactase Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 108010005774 beta-Galactosidase Proteins 0.000 description 4
- 229940072221 immunoglobulins Drugs 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000012466 permeate Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000000470 constituent Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000012569 microbial contaminant Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 229940108461 rennet Drugs 0.000 description 3
- 108010058314 rennet Proteins 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- 241000193163 Clostridioides difficile Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 229940027941 immunoglobulin g Drugs 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920002492 poly(sulfone) Polymers 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000011045 prefiltration Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 229920009405 Polyvinylidenefluoride (PVDF) Film Polymers 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000001516 effect on protein Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000000369 enteropathogenic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229960000380 propiolactone Drugs 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C2210/00—Physical treatment of dairy products
- A23C2210/20—Treatment using membranes, including sterile filtration
- A23C2210/206—Membrane filtration of a permeate obtained by ultrafiltration, nanofiltration or microfiltration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C2210/00—Physical treatment of dairy products
- A23C2210/20—Treatment using membranes, including sterile filtration
- A23C2210/208—Removal of bacteria by membrane filtration; Sterile filtration of milk products
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Water Supply & Treatment (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Dairy Products (AREA)
- Peptides Or Proteins (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatment Of Steel In Its Molten State (AREA)
- Liquid Crystal Substances (AREA)
- Disintegrating Or Milling (AREA)
- General Preparation And Processing Of Foods (AREA)
- Furnace Housings, Linings, Walls, And Ceilings (AREA)
- Nonmetallic Welding Materials (AREA)
- Percussion Or Vibration Massage (AREA)
Claims (12)
1. Förfarande för behandling av ramjölk sä att man minskar den bio-logiska belastningen i rämjölken och samtidigt bibehäller den höga halten av 5 aktivt protein, varvid man tillhandahäller ramjölk, avlägsnar fettet därur, mikro-filtrerar den och tar tillvara filtratet, kännetecknat av, att man pä rämjölken frän vilken fettet avlägsnats utför cross-flow mikrofiltrering (CFMF) under användning av en tangentialströmsfiltrerings (TFF) -anordning med öppna kanaler och ett filter med en porstorlek pä 0,1 - 0,5 pm. 10
2. Förfarande enligt patentkrav 1, kännetecknat av att man utför CFMF genom att använda ett filter med porstorleken ca 0,2 pm.
3. Förfarande enligt patentkrav 1 eller 2, kännetecknat av att man utför CFMF genom att använda ett filter som innehäller en hydrofilise-rad polyvinylidenfluorid (PVDF) -membran. 15
4. Förfarande enligt vilket som heist av ovanstäende patentkrav, kännetecknat av att man tillhandahäller rämjölken inom 48 timmar frän det kon kalvat.
5. Förfarande enligt vilket som heist av ovanstäende patentkrav, kännetecknat av att rämjölken dessutom klarnas före CFMF. 20
6. Förfarande enligt vilket som heist av ovanstäende patentkrav, k ä n n e t e c k n a t av att man efter CFMF utför sterilfiltrering genom ett filter ; . vars porstorlek är 0,2 - 0,45 pm.
7. Förfarande enligt vilket som heist av ovanstäende patentkrav, kännetecknat av att man dessutom torkar det tillvaratagna filtratet. 25
8. Förfarande enligt vilket som heist av ovanstäende patentkrav, .·.· kännetecknat av att rämjölken tillhandahälls frän ett däggdjur, som im- muniserats.
9. Förfarande enligt vilket som heist av ovanstäende patentkrav, kännetecknat av att CFMF-steget utförs vid en temperatur pä högst 40 30 °C.
10. Förfarande enligt patentkrav 9, kännetecknat av att CFMF-steget utförs vid en temperatur pä högst 15 °C. 14 110752
11. Rämjölk, kännetecknad avatt den behandlats enligt för-farandet enligt vilket som heist av patentkraven 1-10.
12. Användning av rämjölken enligt patentkrav 11 för framställning av kliniska näringspreparat, funktionella livsmedel eller tillsatsmedel för livs- 5 medel, vilka innehäller nämnda ramjölk. I I »
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI991186A FI110752B (sv) | 1999-05-25 | 1999-05-25 | Förfarande för behandling av råmjölk |
| ES00660088T ES2234552T3 (es) | 1999-05-25 | 2000-05-17 | Un metodo para tratamiento de calostro. |
| PT00660088T PT1055372E (pt) | 1999-05-25 | 2000-05-17 | Metodo para o tratamento de colostro |
| AT00660088T ATE284619T1 (de) | 1999-05-25 | 2000-05-17 | Verfahren zur behandlung von kolostrum |
| EP00660088A EP1055372B1 (en) | 1999-05-25 | 2000-05-17 | A method of treating colostrum |
| DE60016668T DE60016668T2 (de) | 1999-05-25 | 2000-05-17 | Verfahren zur Behandlung von Kolostrum |
| DK00660088T DK1055372T3 (da) | 1999-05-25 | 2000-05-17 | Fremgangsmåde til behandling af colostrum |
| US09/577,335 US6426109B1 (en) | 1999-05-25 | 2000-05-23 | Method of treating colostrum |
| CA002309226A CA2309226A1 (en) | 1999-05-25 | 2000-05-24 | A method of treating colostrum |
| JP2000154760A JP3616955B2 (ja) | 1999-05-25 | 2000-05-25 | 初乳を処理する方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI991186A FI110752B (sv) | 1999-05-25 | 1999-05-25 | Förfarande för behandling av råmjölk |
| FI991186 | 1999-05-25 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI991186A0 FI991186A0 (sv) | 1999-05-25 |
| FI991186A FI991186A (sv) | 2000-11-26 |
| FI110752B true FI110752B (sv) | 2003-03-31 |
Family
ID=8554729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI991186A FI110752B (sv) | 1999-05-25 | 1999-05-25 | Förfarande för behandling av råmjölk |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6426109B1 (sv) |
| EP (1) | EP1055372B1 (sv) |
| JP (1) | JP3616955B2 (sv) |
| AT (1) | ATE284619T1 (sv) |
| CA (1) | CA2309226A1 (sv) |
| DE (1) | DE60016668T2 (sv) |
| DK (1) | DK1055372T3 (sv) |
| ES (1) | ES2234552T3 (sv) |
| FI (1) | FI110752B (sv) |
| PT (1) | PT1055372E (sv) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002191287A (ja) * | 2000-12-26 | 2002-07-09 | Ogawa & Co Ltd | 抗体含有乳の除菌方法、並びに除菌処理された抗体含有乳を含む食品等 |
| US6875459B2 (en) * | 2001-09-10 | 2005-04-05 | Henry B. Kopf | Method and apparatus for separation of milk, colostrum, and whey |
| ES2588527T3 (es) * | 2006-12-08 | 2016-11-03 | Prolacta Bioscience, Inc. | Composiciones de lípidos humanos y procedimientos de preparación y utilización de los mismos |
| WO2008124870A1 (en) * | 2007-04-11 | 2008-10-23 | Anadis Ltd | Delivery of flu antibodies to surfaces in contact with air |
| DE102011008579A1 (de) * | 2010-08-12 | 2012-02-16 | Lr Health & Beauty Systems Gmbh | Verfahren zur Herstellung eines Kolostrum-Produktes und Vorrichtung zur Durchführung des Verfahrens |
| KR101021571B1 (ko) * | 2010-08-31 | 2011-03-16 | 레이져라이팅(주) | 파티클 세정수단을 구비한 도광판 레이저 가공장치 |
| AT511184A2 (de) * | 2011-02-24 | 2012-09-15 | Ocs Colostrum Vitalplus Gmbh | Verfahren zur herstellung eines lactosearmen oder lactosefreien colostralmilchprodukts sowie colostralmilchprodukt und verwendung desselben |
| CA2902990C (en) | 2013-03-13 | 2021-11-16 | Prolacta Bioscience, Inc. | High fat human milk products |
| WO2015087981A1 (ja) * | 2013-12-13 | 2015-06-18 | 医療法人再生未来 | ウシ初乳酵素処理物、その製造方法、組成物および飲食品 |
| CN105981908B (zh) * | 2015-01-27 | 2020-02-11 | 内蒙古伊利实业集团股份有限公司 | 一种添加牛初乳的液态乳制品及其制备方法 |
| CN105981806B (zh) * | 2015-01-27 | 2020-01-07 | 内蒙古伊利实业集团股份有限公司 | 一种添加牛初乳的发酵类乳制品及其制备方法 |
| CN105981829B (zh) * | 2015-01-27 | 2020-01-10 | 内蒙古伊利实业集团股份有限公司 | 一种无菌液态牛初乳制品及其制备方法与应用 |
| JP6579604B2 (ja) * | 2015-05-20 | 2019-09-25 | 再生ファーマ株式会社 | 育毛・発毛促進剤 |
| JP6579603B2 (ja) * | 2015-05-20 | 2019-09-25 | 再生ファーマ株式会社 | アレルギー疾患の予防改善剤 |
| JP6555738B2 (ja) * | 2015-05-20 | 2019-08-07 | 再生ファーマ株式会社 | 疲労を伴う疾患の予防改善剤 |
| JP6579605B2 (ja) * | 2015-05-20 | 2019-09-25 | 再生ファーマ株式会社 | 皮膚改善剤 |
| IL303044B1 (en) | 2015-12-30 | 2025-01-01 | Prolacta Bioscience Inc | Human milk products used before and after active treatment |
| ITUB20160137A1 (it) * | 2016-02-04 | 2017-08-04 | Innomed S A | Processo di estrazione da colostro |
| WO2019021308A1 (en) * | 2017-07-25 | 2019-01-31 | Rajesh Patil | PROCESS FOR THE PREPARATION OF COLOSTRUM FREE OF DRY BACTERIA AND ITS COLOSTRUM |
| US10385094B2 (en) | 2017-07-26 | 2019-08-20 | Dustin Kjelden | Colostrum solid extraction process |
| WO2020203635A1 (ja) * | 2019-03-29 | 2020-10-08 | 森永乳業株式会社 | ホエイの製造方法及びホエイ |
| BR112022009908A2 (pt) * | 2019-11-21 | 2022-08-09 | Spraying Systems Co | Produto de leite em pó seco por pulverização eletrostática e método para fornecer um produto de leite em pó |
| WO2022148549A1 (en) | 2020-01-14 | 2022-07-14 | Babylat Gmbh | Apparatus and method for obtaining protein-enriched fractions from breast milk |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3911108A (en) | 1973-02-14 | 1975-10-07 | Diamond Shamrock Corp | Process of producing bovine milk products containing specific antibodies |
| US4140806A (en) | 1975-02-27 | 1979-02-20 | Alfa-Laval Ab | Filtering method for separating skim milk from milk products |
| CH627079A5 (en) | 1977-04-15 | 1981-12-31 | Nestle Sa | Process for preparing a protein concentrate containing immunological factors of milk origin |
| DE3432718C1 (de) * | 1984-09-06 | 1986-05-22 | Biotest Pharma GmbH, 6000 Frankfurt | Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen |
| SE451791B (sv) | 1984-09-11 | 1987-11-02 | Alfa Laval Food & Dairy Eng | Sett och anleggning for framstellning av mjolk med lag bakteriehalt |
| US4784850A (en) | 1985-09-04 | 1988-11-15 | Mutzarei Maabarot | Process for preparing antibodies against E. Coli K-99 antigen from bovine milk |
| DE3743440A1 (de) | 1987-12-21 | 1989-06-29 | Gauri Kailash Kumar | Verfahren zum trennen der geloesten und ungeloesten bestandteile von milch |
| FR2628973B1 (fr) * | 1988-03-25 | 1990-11-16 | Gattefosse Ets Sa | Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition |
| DE4026365A1 (de) * | 1990-08-21 | 1992-02-27 | Biotest Pharma Gmbh | Sterilfiltrierte kolostralmilch |
| US5256437A (en) | 1992-06-19 | 1993-10-26 | Pall Corporation | Product and process of making sterile milk through dynamic microfiltration |
| DK169510B1 (da) | 1993-05-13 | 1994-11-14 | Apv Pasilac As | Anlæg og fremgangsmåde til behandling af mælk |
| FI97269B (sv) * | 1993-10-12 | 1996-08-15 | Viable Bioproducts Ltd | Förfarande för framställning av näringsdryck |
| US5707678A (en) | 1995-04-12 | 1998-01-13 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
| US5670196A (en) * | 1995-04-12 | 1997-09-23 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
| AUPN642795A0 (en) | 1995-11-08 | 1995-11-30 | Northfield Laboratories Pty Ltd | Dairy compositions and methods of preparing same |
| DE19619990A1 (de) * | 1996-05-17 | 1997-11-20 | Charlotte Adler | Verfahren zur Herstellung von Kolostralmilchprodukten sowie deren Verwendung |
| JP2002512055A (ja) * | 1998-04-29 | 2002-04-23 | ホネロプ，ケール | 初乳の調製方法 |
-
1999
- 1999-05-25 FI FI991186A patent/FI110752B/sv not_active IP Right Cessation
-
2000
- 2000-05-17 EP EP00660088A patent/EP1055372B1/en not_active Expired - Lifetime
- 2000-05-17 AT AT00660088T patent/ATE284619T1/de not_active IP Right Cessation
- 2000-05-17 ES ES00660088T patent/ES2234552T3/es not_active Expired - Lifetime
- 2000-05-17 DE DE60016668T patent/DE60016668T2/de not_active Expired - Fee Related
- 2000-05-17 DK DK00660088T patent/DK1055372T3/da active
- 2000-05-17 PT PT00660088T patent/PT1055372E/pt unknown
- 2000-05-23 US US09/577,335 patent/US6426109B1/en not_active Expired - Fee Related
- 2000-05-24 CA CA002309226A patent/CA2309226A1/en not_active Abandoned
- 2000-05-25 JP JP2000154760A patent/JP3616955B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI991186A (sv) | 2000-11-26 |
| EP1055372B1 (en) | 2004-12-15 |
| DE60016668T2 (de) | 2005-12-08 |
| CA2309226A1 (en) | 2000-11-25 |
| DK1055372T3 (da) | 2005-03-29 |
| US6426109B1 (en) | 2002-07-30 |
| ES2234552T3 (es) | 2005-07-01 |
| ATE284619T1 (de) | 2005-01-15 |
| JP3616955B2 (ja) | 2005-02-02 |
| FI991186A0 (sv) | 1999-05-25 |
| PT1055372E (pt) | 2005-04-29 |
| DE60016668D1 (de) | 2005-01-20 |
| EP1055372A2 (en) | 2000-11-29 |
| EP1055372A3 (en) | 2000-12-27 |
| JP2001017078A (ja) | 2001-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI110752B (sv) | Förfarande för behandling av råmjölk | |
| US8669353B2 (en) | Process for producing milk fractions rich in secretory immunoglobulins | |
| EP0697816B1 (en) | A plant and a method of treating milk | |
| CN103039630A (zh) | 具有天然免疫活性的无菌牛初乳乳清及其制备方法和应用 | |
| WO2001003515A9 (en) | Method of obtaining protein isolates and concentrates from colostrum | |
| US20210360939A1 (en) | Low-bacteria milk powders with a high whey protein nitrogen index (iv) | |
| US20130344219A1 (en) | Low-bacteria low-heat whole milk powder | |
| US9475860B2 (en) | Process for obtaining immunoglobulins from colostral milk | |
| CA2932365C (en) | Process for the production of near sterile whey protein concentrates | |
| US7547770B2 (en) | Colostral fractionation process | |
| CN114586847B (zh) | 一种鲜奶级母乳化牛乳蛋白基料及其制备方法 | |
| ES2260281T3 (es) | Metodo para filtrar leche. | |
| AU2010338115A1 (en) | Method for reducing the bacterial content of a food and/or biological medium of interest containing lipid droplets | |
| CN114206120A (zh) | 从生山羊奶去除孢子的方法、制备纯化山羊奶的方法、所产山羊奶和其用途及奶酪制作方法 | |
| Goswami et al. | Elimination of Pathogenic Bacteria From Milk Using Membrane Technology: A Review | |
| Mulvihill et al. | Production of whey-protein-enriched products | |
| WO2002072117A1 (en) | Peptide-isolation process and product made thereby | |
| CN118542356A (zh) | 高新鲜度脱盐乳清原料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |